These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 16080523

  • 1. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F, Zaiss I, Herzog D, Götte K, Naim R, Hörmann K.
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
    Pauli C, Stieber P, Schmitt UM, Andratschke M, Hoffmann K, Wollenberg B.
    Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN.
    Cancer; 2008 Aug 15; 113(4):750-7. PubMed ID: 18536030
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
    Van Hal NL, Van Dongen GA, Ten Brink CB, Heider KH, Rech-Weichselbraun I, Snow GB, Brakenhoff RH.
    Clin Cancer Res; 1999 Nov 15; 5(11):3534-41. PubMed ID: 10589769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM, Moore-Medlin T, McClure GB, Ekshyyan O, Vanchiere JA, Nathan CA.
    JAMA Otolaryngol Head Neck Surg; 2014 Jan 15; 140(1):5-11. PubMed ID: 24232368
    [Abstract] [Full Text] [Related]

  • 12. Defining cancer cachexia in head and neck squamous cell carcinoma.
    Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, Cannon T, Stewart PW, Weissler MC, Shores CG.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6561-7. PubMed ID: 18006755
    [Abstract] [Full Text] [Related]

  • 13. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
    Tartour E, Deneux L, Mosseri V, Jaulerry C, Brunin F, Point D, Validire P, Dubray B, Fridman WH, Rodriguez J.
    Cancer; 1997 Apr 01; 79(7):1401-8. PubMed ID: 9083163
    [Abstract] [Full Text] [Related]

  • 14. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T.
    Clin Cancer Res; 2005 May 01; 11(9):3257-64. PubMed ID: 15867221
    [Abstract] [Full Text] [Related]

  • 15. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG, Schmidt A, Nehls O, Kaiser S.
    Oral Oncol; 2008 Jan 01; 44(1):78-85. PubMed ID: 17350326
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
    Gokhale AS, Haddad RI, Cavacini LA, Wirth L, Weeks L, Hallar M, Faucher J, Posner MR.
    Oral Oncol; 2005 Jan 01; 41(1):70-6. PubMed ID: 15598588
    [Abstract] [Full Text] [Related]

  • 18. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
    Kizilay A, Kalcioğlu MT, Ozuğurlu F, Ozyurt H, Aladağ I, Ozturan O, Akyol O.
    Kulak Burun Bogaz Ihtis Derg; 2007 Jan 01; 17(3):148-51. PubMed ID: 17873505
    [Abstract] [Full Text] [Related]

  • 19. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma.
    Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, Hazama S, Hirazawa K, Hayashi H, Tangoku A, Hirose K, Ishihara T, Suzuki T.
    Cancer Res; 1996 Jun 15; 56(12):2776-80. PubMed ID: 8665513
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
    Kawakami M, Kawakami K, Kasperbauer JL, Hinkley LL, Tsukuda M, Strome SE, Puri RK.
    Clin Cancer Res; 2003 Dec 15; 9(17):6381-8. PubMed ID: 14695138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.